These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 362256)
1. Myocardial re-infarction and sulphinpyrazone. N Z Med J; 1978 Aug; 88(617):106. PubMed ID: 362256 [No Abstract] [Full Text] [Related]
2. Sulphinpyrazone (Anturan) after myocardial infarction. Nicholson MR; Whitlock RM N Z Med J; 1979 Sep; 90(644):263. PubMed ID: 390442 [No Abstract] [Full Text] [Related]
3. Decrease in renal function due to sulphinpyrazone treatment early after myocardial infarction. Lijnen P; Boelaert J; van Eeghem P; Daneels R; Schurgers M; de Jaegere P; van der Stichele E; Vincke J; Fagard R; Verschueren LJ; Amery A Clin Nephrol; 1983 Mar; 19(3):143-6. PubMed ID: 6340878 [TBL] [Abstract][Full Text] [Related]
5. Sulphinpyrazone (Anturan) after myocardial infarct. Watt M N Z Med J; 1979 Oct; 90(646):352. PubMed ID: 392352 [No Abstract] [Full Text] [Related]
6. Sulphinpyrazone in the prevention of cardiac death after myocardial infarction. S Afr Med J; 1980 Mar; 57(9):301-2. PubMed ID: 6986664 [No Abstract] [Full Text] [Related]
7. Sulfinpyrazone after myocardial infarction. N Engl J Med; 1978 Jun; 298(22):1257-9. PubMed ID: 349383 [No Abstract] [Full Text] [Related]
15. A serial study of platelet reactivity throughout the first six months after myocardial infarction: its modification by sulphinpyrazone. Kubik MM; Richardson SG Postgrad Med J; 1987 May; 63(739):351-6. PubMed ID: 3118351 [TBL] [Abstract][Full Text] [Related]
20. [Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct]. Rühle H Z Arztl Fortbild (Jena); 1985; 79(11):463-6. PubMed ID: 3901541 [No Abstract] [Full Text] [Related] [Next] [New Search]